ClassID:

92736

C07C233/11 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings

Recent Application in this class:
#1
20260109664
2026-04-23

COMPOUNDS FOR USE AS MEDICAMENTS

#2
20250346556
2025-11-13

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

#3
20250145561
2025-05-08

4-SUBSTITUTED-PHENYL ACETAMIDES AND ARYLUREAS AS AGONISTS FOR THE ORPHAN RECEPTOR GPR88

#4
20250019341
2025-01-16

COMPOUNDS AND METHOD OF USE THEREOF FOR TREATING BACTERIAL DISEASES

#5
20250017890
2025-01-16

CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF

#6
20240239739
2024-07-18

COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

#7
20240018119
2024-01-18

CARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS

#8
20230278994
2023-09-07

HETEROCYCLYL PYRIMIDINES AND TRIAZINES AS NOVEL FUNGICIDES

#9
20230242572
2023-08-03

a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#10
20230098716
2023-03-30

FLUORENE DERIVATIVE, AND PRODUCTION METHOD AND USE FOR SAME

#11
20230063230
2023-03-02

NURR1 RECEPTOR MODULATORS

#12
20220401401
2022-12-22

CARBAMOYL PHENYLALANINOL ANALOGS AND USES THEREOF

#13
20220396551
2022-12-15

EBNA1 inhibitors and their method of use

#14
20220386609
2022-12-08

META-DIAMIDE INSECTICIDES

#15
20220332675
2022-10-20

IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

#16
20220291164
2022-09-15

Solid-state magnesium ion selective microelectrode and methods of production and use thereof

#17
20220279787
2022-09-08

a-Substituted Phenyl Structure-Containing Compound, Preparation Method Thereof, and Disinfectant

#18
20220274926
2022-09-01

Immunoregulatory agents

#19
20220227698
2022-07-21

Thyromimetics with a biphenylmethane scaffold and their use

#20
20220040174
2022-02-10

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#21
20220033347
2022-02-03

Crystalline form a of 2, 2-bis(4-fluorophenyl)-2-phenylacetamide and preparation method therefor and application thereof

#22
20210401836
2021-12-30

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#23
20210286266
2021-09-16

Material for forming organic film, method for forming organic film, patterning process, and compound

#24
20210130301
2021-05-06

Compositions for the treatment of pulmonary fibrosis

#25
20210130285
2021-05-06

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

#26
20210093603
2021-04-01

Carbamoyl phenylalaninol analogs and uses thereof

#27
20210002208
2021-01-07

Derivatives of sobetirome

#28
20200361849
2020-11-19

Thyromimetics

#29
20200290950
2020-09-17

ALKAMIDE COMPOUNDS AND USES THEREOF

#30
20200247762
2020-08-06

K-Ras modulators

#31
20200181078
2020-06-11

EBNA1 inhibitors and their method of use

#32
20200079721
2020-03-12

Sacubitril intermediate and preparation method thereof

#33
20200024220
2020-01-23

Method for preparing 2-aryl malonamide and applications thereof

#34
20190381042
2019-12-19

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#35
20190374541
2019-12-12

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#36
20190270712
2019-09-05

Compositions for the treatment of pulmonary fibrosis

#37
20190201365
2019-07-04

α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof

#38
20190185417
2019-06-20

NOVEL ANTIBIOTICS

#39
20190104756
2019-04-11

Solutions and dispersions of amide compounds

#40
20190092729
2019-03-28

Immunoregulatory agents

#41
20190039999
2019-02-07

CELL SEEDING PLATE, METHOD FOR MANUFACTURING THE SAME, AND CELL SHEET SEPARATING METHOD

#42
20180362439
2018-12-20

Sacubitril intermediate and preparation method thereof

#43
20180289704
2018-10-11

Compounds useful as modulators of TRPM8

#44
20180273478
2018-09-27

Anti-cancer compounds

#45
20180104243
2018-04-19

Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction

#46
20180093997
2018-04-05

Use of physiological cooling active ingredients, and agents containing such active ingredients

#47
20180086699
2018-03-29

EBNA1 inhibitors and their method of use

#48
20180022679
2018-01-25

Heterogeneous metal-free catalyst

#49
20170334835
2017-11-23

Non-lactone carbocyclic modulators of bacterial quorum sensing

#50
20170304255
2017-10-26

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

#51
20170216241
2017-08-03

α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof

#52
20160317532
2016-11-03

Compounds useful as modulators of TRPM8

#53
20160289185
2016-10-06

EBNA1 inhibitors and their method of use

#54
20160137592
2016-05-19

Compounds advantageous in the treatment of central nervous system diseases and disorders

#55
20160052866
2016-02-25

Intermediate used for preparing tapentadol or analogues thereof

#56
20160009926
2016-01-14

Functionalised antifouling compounds and use thereof

#57
20150183715
2015-07-02

Alpha- and gamma-truxillic acid derivatives and pharmaceutical compositions thereof

#58
20150119365
2015-04-30

Activators of glucokinase

#59
20150111749
2015-04-23

Use of sarmentine and its analogs for controlling plant pests

#60
20150086491
2015-03-26

Use of physiological cooling active ingredients, and agents containing such active ingredients

#61
20150051419
2015-02-19

Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium

#62
20140323520
2014-10-30

Compositions and methods for increasing proliferation of adult salivary stem cells

#63
20140296294
2014-10-02

Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases

#64
20140248236
2014-09-04

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#65
20140142156
2014-05-22

Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing

#66
20140039189
2014-02-06

Process for the preparation of acylguanidines and acylthioureas

#67
20140018578
2014-01-16

Method for the synthesis of rasagiline

#68
20140018549
2014-01-16

USE OF D-SERINE DERIVATIVES FOR THE TREATMENT OF ANXIETY DISORDERS

#69
20130324557
2013-12-05

Compounds useful as modulators of TRPM8

#70
20130281294
2013-10-24

Use of sarmentine and its analogs for controlling plant pests

#71
20130253218
2013-09-26

PROCESS FOR PREPARING PROSTAGLANDIN DERIVATIVES

#72
20130245065
2013-09-19

Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium

#73
20130231478
2013-09-05

Intermediate for preparing tapentadol or analogues thereof

#74
20130190397
2013-07-25

Compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient

#75
20130123356
2013-05-16

Modulator

#76
20130109856
2013-05-02

NOVEL PROCESS FOR THE PREPARATION OF ACYLGUANIDINES AND ACYLTHIOUREAS

#77
20130096344
2013-04-18

Nitrile hydration catalyzed by recyclable ruthenium complexes

#78
20120302541
2012-11-29

4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators

#79
20120301423
2012-11-29

Functionalised antifouling compounds and use thereof

#80
20120289512
2012-11-15

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#81
20120263659
2012-10-18

Use of physiological cooling active ingredients, and agents containing such active ingredients

#82
20120245363
2012-09-27

PROCESS FOR THE SYNTHESIS OF AGOMELATINE

#83
20120220768
2012-08-30

Process of forming an amide

#84
20120142771
2012-06-07

BIPHENYLACETAMIDE DERIVATIVE

#85
20120115714
2012-05-10

Catalyst precursor, method for producing the same, method for using the same, and reactor that uses the same

#86
20120108839
2012-05-03

Process for preparing prostaglandin derivatives

#87
20110319636
2011-12-29

METHOD FOR PREPARATION OF AMIDES FROM ALCOHOLS AND AMINES BY EXTRUSION OF HYDROGEN

#88
20110313196
2011-12-22

NOVEL PROCESS

#89
20110294758
2011-12-01

Activators of glucokinase

#90
20110288175
2011-11-24

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#91
20110230465
2011-09-22

VIRAL POLYMERASE INHIBITORS

#92
20110224304
2011-09-15

BIPHENYLACETAMIDE DERIVATIVE

#93
20110046195
2011-02-24

Non-lactone carbocyclic and heterocyclic antagonists and agonists of bacterial quorum sensing

#94
20110046138
2011-02-24

Compounds advantageous in the treatment of central nervous system diseases and disorders

#95
20110021358
2011-01-27

Use of sarmentine and its analogs for controlling plant pests

#96
20110004020
2011-01-06

Process for producing organic carboxylic acid amides

#97
20100331574
2010-12-30

HYDROXYAPATITE WITH SILVER SUPPORTED ON THE SURFACE THEREOF

#98
20100261772
2010-10-14

Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators

#99
20100145060
2010-06-10

Schwartz reagents: methods of in situ generation and use

#100
20100144876
2010-06-10

Modulator

#101
20100137401
2010-06-03

2-METHYLPROP ANAMIDES AND THEIR USE AS PHARMACEUTICALS

#102
20100130785
2010-05-27

Process for preparing secondary amides by carbonylation of a corresponding tertiary amine

#103
20100121069
2010-05-13

METHOD FOR MANUFACTURING A BETA-DIARYL ELECTRON WITHDRAWING GROUP SUBSTITUTED COMPOUND

#104
20100099768
2010-04-22

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#105
20100069454
2010-03-18

Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection

#106
20100036162
2010-02-11

Process for the synthesis of agomelatine

#107
20100016403
2010-01-21

Use of D-serine derivatives for the treatment of anxiety disorders

#108
20090281085
2009-11-12

3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity

#109
20090203667
2009-08-13

PENTADIENAMIDE DERIVATIVES

#110
20090182020
2009-07-16

SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS

#111
20090176783
2009-07-09

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#112
20090163557
2009-06-25

Cannabinergic lipid ligands

#113
20090163547
2009-06-25

Indene derivatives, their preparation and use as medicaments

#114
20090156849
2009-06-18

Catalyst for asymmetric synthesis, ligand for use therein, and process for producing optically active compound through asymmetric synthesis reaction using them

#115
20090149510
2009-06-11

Compositions and methods for modulating a kinase cascade

#116
20090131441
2009-05-21

Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them

#117
20090118290
2009-05-07

Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

#118
20090111874
2009-04-30

Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof

#119
20090099186
2009-04-16

INHIBITORS OF VIRAL REPLICATION

#120
20090069536
2009-03-12

Amide forming chemical ligation

#121
20080167360
2008-07-10

Cycloalkylidene compounds as selective estrogen receptor modulators

#122
20080114062
2008-05-15

Modulator

#123
20080096869
2008-04-24

Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors

#124
20070299114
2007-12-27

Biaryl Derivatives

#125
20070259964
2007-11-08

Process for the preparation of cinacalcet base

#126
20070244198
2007-10-18

Carboxylic Derivatives

#127
20070179186
2007-08-02

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#128
20070161607
2007-07-12

Potassium channel modulators

#129
20070060773
2007-03-15

Amide forming chemical ligation

#130
20070060752
2007-03-15

1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases

#131
20070027205
2007-02-01

Diarylmethyl derivatives as potassium channel modulators

#132
20070027158
2007-02-01

High affinity small molecule C5a receptor modulators

#133
20070003680
2007-01-04

Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers

#134
20060258866
2006-11-16

Carboxylic derivates

#135
20060247441
2006-11-02

Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles

#136
20060171882
2006-08-03

Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled compounds by thermally induced free radical carbonylation

#137
20060149070
2006-07-06

Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme

#138
20060142594
2006-06-29

Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases

#139
20060135620
2006-06-22

Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection

#140
20060079506
2006-04-13

Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors

#141
20060004062
2006-01-05

Compounds for inhibiting insulin secretion and methods related thereto

#142
20050288329
2005-12-29

2-methylprop anamides and their use as pharmaceuticals

#143
20050282822
2005-12-22

Therapeutic agents

#144
20050267168
2005-12-01

Pentanoic acid derivatives

#145
20050267167
2005-12-01

Pentanoic acid derivatives

#146
20050261371
2005-11-24

Pentanoic acid derivatives

#147
20050250839
2005-11-10

Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity

#148
20050197511
2005-09-08

Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells

#149
20050148656
2005-07-07

Carboxylic derivates

#150
20050054882
2005-03-10

Diaryl ether condensation reactions

#151
20050009816
2005-01-13

Potassium channel modulators